oxonic acid has been researched along with Invasiveness, Neoplasm in 78 studies
Oxonic Acid: Antagonist of urate oxidase.
Excerpt | Relevance | Reference |
---|---|---|
"We treated a patient with inoperable advanced gastric cancer and malignant ascites by combination chemotherapy of TS-1 and biweekly paclitaxel (TXL)." | 3.72 | [A patient with advanced gastric cancer that response remarkably to combination chemotherapy of TS-1 and biweekly paclitaxel (TXL)]. ( Funai, S; Hirai, T; Kamei, A; Ohtsuka, H; Shindo, K; Shiozaki, H; Tanaka, A; Yoshifuji, T, 2003) |
" The other 36 received CRC at the same cisplatin and radiotherapy dosage as for CRSC." | 2.82 | Concurrent radiotherapy with S-1 plus cisplatin versus concurrent radiotherapy with cisplatin alone for the treatment of locally advanced cervical carcinoma: a pilot randomised controlled trial. ( Han, S; Li, Z; Lin, N; Mao, W, 2016) |
"An 80-year-old man with a local recurrence of gastric cancer was treated with S-1 monotherapy leading to a complete response(CR)." | 2.53 | [An Elderly Patient with Local Recurrence of Gastric Cancer Responding Completely to S-1 Monotherapy]. ( Hasegawa, M; Ichikawa, K; Kokado, Y; Koshiba, T; Kusama, T; Sone, N; Yamagami, K, 2016) |
"A 72-year-old man with advanced gastric cancer was referred to our hospital." | 2.49 | [A case of locally advanced gastric cancer in which pathological complete response( PCR) was obtained after combination chemotherapy with S-1/cisplatin]. ( Fujino, M; Hasegawa, A; Kametaka, H; Koyama, T; Makino, H; Matsuo, M; Seike, K; Yokoyama, M, 2013) |
"Unresectable pancreatic cancer (UR-PC) has a poor prognosis." | 1.56 | Role of Conversion Surgery for Unresectable Pancreatic Cancer After Long-Term Chemotherapy. ( Endo, I; Kumamoto, T; Matsuyama, R; Murakami, T; Sawada, Y; Tsuchiya, N; Yabushita, Y, 2020) |
"The patient with gallbladder cancer and tumor thrombus in the portal vein described in this report provides a reminder for surgeons of the importance of early diagnosis, and adequate surgical and adjuvant treatment." | 1.48 | Gallbladder cancer with tumor thrombus in the portal vein: A case report. ( Bai, XL; Chen, W; Liang, TB; Ma, T; Tu, JJ; Zhang, XZ, 2018) |
"We encountered a case of type 4 gastric cancer with esophageal invasion that responded to neoadjuvant chemotherapy containing S-1 and oxaliplatin(SOX)followed by surgery, which could be curative resection." | 1.48 | [A Case of Type 4 Gastric Cancer with Esophageal Invasion That Responded to Neoadjuvant Chemotherapy Containing S-1 and Oxaliplatin followed by Surgery]. ( Fujimura, T; Hagino, S; Izumi, R; Kitagawa, H; Kurata, T; Saito, K; Sasaki, S; Shoji, Y; Terada, I; Yoshikawa, A, 2018) |
"On the other hand, the 2014 Japanese gastric cancer treatment guidelines(ver." | 1.46 | [A Case of Duodenal Invasive Advanced Gastric Cancer in Which the Primary Tumor Achieved pCR, but Viable Cancer Cells Remained in Lymph Node No.13 after Neoadjuvant Chemotherapy]. ( Choda, Y; Harano, M; Idani, H; Ishida, M; Kubota, T; Matsukawa, H; Miyake, S; Morito, T; Nakano, K; Ojima, Y; Okajima, M; Sato, D; Shiozaki, S; Sumitani, D, 2017) |
"The prognosis of advanced gastric cancer was significantly related to the start of S-1 adjuvant treatment within 6 weeks after surgery." | 1.43 | S-1 Adjuvant Chemotherapy Earlier After Surgery Clinically Correlates with Prognostic Factors for Advanced Gastric Cancer. ( Egashira, A; Ikeda, Y; Kinjo, N; Minami, K; Morita, M; Okamura, T; Sakaguchi, Y; Toh, Y; Yamaguchi, S; Yamamoto, M, 2016) |
"The prognosis of Stage IV b pancreatic cancer is extremely poor; the mean survival time is 2-4 months." | 1.42 | [A case of stage IV b pancreatic head cancer that was resected because of a good response to chemotherapy]. ( Fujino, Y; Goto, H; Hasegawa, H; Kakinoki, K; Katsura, M; Ohara, T; Oshikiri, T; Oyama, M; Sendo, H; Sugimoto, T; Sugiyama, H; Tominaga, M; Ueda, Y; Yamashita, H; Yasuda, T, 2015) |
"For patients in the experimental group (cetuximab in combination with SOX (Ce-SOX), 30 patients), once-weekly cetuximab (400 mg/m2 at the first infusion then 250 mg/m2 every week) was administered." | 1.40 | Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer. ( Chen, XB; Hua, YW; Kong, Y; Liu, HX; Ma, EM; Yang, W; Zhang, B; Zhang, YL; Zhang, ZD, 2014) |
"A 62-year-old woman diagnosed with gallbladder cancer exhibiting broad liver invasion and metastasis to Couinaud's hepatic segments 4 and 8 (S4 and S8) consulted her regular doctor." | 1.40 | Curative resection of gallbladder cancer with liver invasion and hepatic metastasis after chemotherapy with gemcitabine plus S-1: report of a case. ( Ide, T; Ide, Y; Kai, K; Kitahara, K; Koga, H; Miyoshi, A; Nakamura, H; Nakamura, J; Noshiro, H; Okumura, T, 2014) |
"A total of 59 patients with stage IV gastric cancer received induction chemotherapy with S-1 and cisplatin." | 1.40 | Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients. ( Kiyozaki, H; Rikiyama, T; Saito, M; Suzuki, K; Takata, O, 2014) |
"A 6 2-year-old man with advanced gastric cancer was referred to our hospital." | 1.40 | [Pathological complete response in a case of advanced gastric cancer after neoadjuvant chemotherapy]. ( Fujiwara, T; Kagawa, S; Kikuchi, S; Kubota, T; Kuroda, S; Kuwada, K; Nishizaki, M; Tanaka, T, 2014) |
"Medical records of 133 patients with extrahepatic cholangiocarcinoma who underwent curative resection were reviewed retrospectively." | 1.39 | Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies. ( Hashimoto, Y; Kondo, N; Murakami, Y; Muto, T; Nakagawa, N; Sasaki, H; Sudo, T; Sueda, T; Uemura, K; Urabe, K, 2013) |
"We experienced two cases of Stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy." | 1.38 | [Two cases of stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy]. ( Azuma, T; Inoue, T; Mori, Y; Ohtani, H; Tamamori, Y, 2012) |
"Advanced gastric cancer was found at the fundus of the stomach, and severe dysplasia was found at the lower esophagus." | 1.38 | [A case of advanced gastric cancer with esophageal severe dysplasia resected after neoadjuvant S-1+cisplatin therapy]. ( Hosaka, S; Inada, K; Kawamoto, S; Kikutake, T; Maeno, H; Nagao, S; Okubo, S; Umemoto, S; Yoshida, T, 2012) |
"In patients with stage II/III gastric cancer, tumors often recur even after curative D2 gastrectomy followed by adjuvant S-1 chemotherapy." | 1.37 | Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1. ( Aoyama, T; Cho, H; Hayashi, T; Ogata, T; Tsuburaya, A; Watanabe, T; Yoshikawa, T, 2011) |
"In the case of pancreatic cancer that CRT is effective to the remission of primary lesion, CRT is potentially useful to perform for the control of metastatic lesion or palliative therapy." | 1.36 | [A 6-year survival case of locally advanced unresectable pancreatic tail cancer treated with chemo-radiation therapy]. ( Aoki, H; Choda, Y; Fujiwara, Y; Harano, M; Matsukawa, H; Ninomiya, M; Nishizaki, M; Ohno, S; Ojima, Y; Shiozaki, S; Takakura, N, 2010) |
"Pancreatic cancer is considered resectable only when there are no distant metastases or infiltration of surrounding organs or arteries." | 1.35 | Curative surgical treatment after preoperative chemotherapy for primarily inoperable locally advanced pancreatic carcinoma: report of a case. ( Dowaki, S; Hirabayashi, K; Imaizumi, T; Makuuchi, H; Matsuyama, M; Okada, K; Tobita, K; Yazawa, N, 2009) |
"A resected case of squamous cell carcinoma associated with ductal carcinoma in the hemilateral breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases is reported with some discussion." | 1.34 | [A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases]. ( Akagawa, T; Fujioka, S; Hara, T; Hiramatsu, K; Hirata, A; Ito, T; Kato, K; Kutsuna, Y; Machiki, Y; Matsuba, H; Miyata, T, 2007) |
"Adjuvant chemotherapy for advanced gastric cancer has not yet been established." | 1.34 | [A case of advanced gastric cancer responding remarkably to neo-adjuvant combination chemotherapy using CPT-11 plus S-1]. ( Gotoh, M; Hashimoto, Y; Hoshino, Y; Kashimura, S; Kogure, M; Odashima, Y; Osuka, F; Otani, S; Saito, T; Saze, Z; Soeta, N; Terashima, M; Watanabe, K, 2007) |
"We report a case of advanced rectal cancer successfully treated with a combination of S-1 and CPT-11 as neoadjuvant chemotherapy." | 1.34 | [Neoadjuvant chemotherapy with combination of S-1 and CPT-11 in advanced rectal cancer - a case report]. ( Han, I; Hatori, S; Iwasaki, H; Murakami, H; Suzuki, M; Takanashi, Y; Yamakawa, M, 2007) |
"We reported a case of unresectable gastric cancer presenting pylorus stenosis treated orally by S-1 therapy in a 72-year-old man who underwent gastrojejunostomy." | 1.34 | [A case of unresectable gastric cancer presenting pylorus stenosis treated orally with S-1 therapy after gastrojejunostomy]. ( Matsui, K; Morita, S; Shinbo, M; Tazawa, K; Tsukada, K; Yamada, A; Yamagishi, F; Yoshida, T, 2007) |
"We report a case of advanced breast cancer (T4b, N3c, M1) achieving a significant improvement on QOL by multi-disciplinary therapy and S-1 administration." | 1.34 | [A case of advanced breast cancer successfully treated with multi-disciplinary therapy and S-1 administration]. ( Amano, S; Enomoto, K; Kitajima, A; Sakurai, K; Tani, M, 2007) |
"We report a patient with gastric cancer successfully treated with TS-1 and low-dose CDDP as neoadjuvant chemotherapy." | 1.33 | [A Case of advanced gastric cancer successfully treated with TS-1/low-dose CDDP as neoadjuvant chemotherapy]. ( Ebina, T; Kawasaki, H; Kobori, H; Sasaki, M; Seino, K; Shibata, S; Sugiyama, Y; Tanaka, M; Yamada, K, 2005) |
"A 72-year-old man was diagnosed as gastric cancer with pyloric stenosis by an upper gastorintestinal endoscopy for anemia in July 2001." | 1.33 | [A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months]. ( Ishizuka, D; Kobayashi, K; Tada, T; Ueki, K; Wakakuwa, R, 2006) |
"We report a case of advanced squamous cell carcinoma in the left buccal mucosa, upper gingiva, and maxillary sinus (T4N0M0) showing a complete response to oral chemotherapy with TS-1." | 1.32 | [An advanced case of squamous cell carcinoma in the left buccal mucosa, upper gingiva, and maxillary sinus (T4N0M0) showing a complete response to chemotherapy with TS-1]. ( Mishima, K; Nakamura, H; Obara, S; Yamamoto, K; Yoshimura, Y, 2004) |
" Beginning on August 9, 1999, TS-1 was administered in a dosage of 50 mg bid, but it was later learned that the patient had ingested only half of that TS-1 dosage (i." | 1.31 | [A case of residual gastric cancer accompanied by esophageal invasion in which residual lesions were eradicated by half-dose administration of TS-1]. ( Abe, S; Kitago, M; Kojima, M; Kurihara, H; Ogihara, T; Sasanuma, H; Tamura, H; Wada, M, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 24 (30.77) | 29.6817 |
2010's | 52 (66.67) | 24.3611 |
2020's | 2 (2.56) | 2.80 |
Authors | Studies |
---|---|
Oneyama, M | 1 |
Sakamoto, N | 1 |
Oue, N | 1 |
Kimura, Y | 2 |
Hiroshima, Y | 1 |
Hashimoto, I | 1 |
Hara, K | 1 |
Maezawa, Y | 1 |
Kano, K | 1 |
Aoyama, T | 2 |
Fujikawa, H | 1 |
Yamada, T | 2 |
Tamagawa, H | 2 |
Yamamoto, N | 1 |
Ogata, T | 2 |
Cho, H | 2 |
Ito, H | 1 |
Yukawa, N | 1 |
Shiozawa, M | 1 |
Yoshikawa, T | 3 |
Morinaga, S | 1 |
Rino, Y | 2 |
Masuda, M | 1 |
Miyagi, Y | 1 |
Yasui, W | 1 |
Oshima, T | 1 |
Nishibeppu, K | 1 |
Komatsu, S | 2 |
Imamura, T | 1 |
Kiuchi, J | 1 |
Kishimoto, T | 1 |
Arita, T | 1 |
Kosuga, T | 1 |
Konishi, H | 2 |
Kubota, T | 3 |
Shiozaki, A | 2 |
Fujiwara, H | 3 |
Okamoto, K | 2 |
Otsuji, E | 2 |
Tsuchiya, N | 1 |
Matsuyama, R | 1 |
Murakami, T | 1 |
Yabushita, Y | 1 |
Sawada, Y | 1 |
Kumamoto, T | 1 |
Endo, I | 2 |
Choda, Y | 2 |
Morito, T | 1 |
Miyake, S | 1 |
Ishida, M | 2 |
Sato, D | 1 |
Sumitani, D | 1 |
Nakano, K | 1 |
Harano, M | 2 |
Matsukawa, H | 2 |
Ojima, Y | 2 |
Idani, H | 1 |
Shiozaki, S | 2 |
Okajima, M | 1 |
Gakuhara, A | 1 |
Miyazaki, Y | 1 |
Takahashi, T | 2 |
Kurokawa, Y | 4 |
Tanaka, K | 1 |
Makino, T | 1 |
Yamasaki, M | 2 |
Nakajima, K | 2 |
Mori, M | 2 |
Doki, Y | 1 |
Zhang, XZ | 1 |
Tu, JJ | 1 |
Chen, W | 1 |
Ma, T | 1 |
Bai, XL | 1 |
Liang, TB | 1 |
Hagino, S | 1 |
Fujimura, T | 1 |
Kurata, T | 1 |
Shoji, Y | 1 |
Sasaki, S | 1 |
Terada, I | 1 |
Yoshikawa, A | 1 |
Kitagawa, H | 1 |
Izumi, R | 1 |
Saito, K | 1 |
Murakami, Y | 2 |
Uemura, K | 2 |
Sudo, T | 2 |
Hashimoto, Y | 3 |
Kondo, N | 2 |
Nakagawa, N | 1 |
Muto, T | 1 |
Sasaki, H | 1 |
Urabe, K | 1 |
Sueda, T | 2 |
Kubo, N | 3 |
Takeuchi, N | 1 |
Nakayama, A | 1 |
Ogiwara, H | 1 |
Masahiro, O | 1 |
Tsujimoto, K | 1 |
Ito, N | 1 |
Shibata, T | 1 |
Sasako, M | 2 |
Sano, T | 2 |
Tsuburaya, A | 3 |
Iwasaki, Y | 2 |
Fukuda, H | 1 |
Murata, A | 1 |
Kimura, K | 3 |
Amano, R | 3 |
Hirata, K | 2 |
Nagahara, H | 2 |
Toyokawa, T | 1 |
Tanaka, H | 2 |
Muguruma, K | 2 |
Otani, H | 1 |
Maeda, K | 2 |
Ohira, M | 2 |
Hirakawa, K | 3 |
Kondo, J | 1 |
Nisimura, T | 1 |
Nagashima, Y | 1 |
Okada, T | 2 |
Nakamura, M | 1 |
Setoguchi, M | 1 |
Yoshino, S | 1 |
Sakata, K | 1 |
Fujino, M | 1 |
Kametaka, H | 1 |
Makino, H | 2 |
Yokoyama, M | 1 |
Matsuo, M | 1 |
Seike, K | 1 |
Koyama, T | 1 |
Hasegawa, A | 1 |
Zhang, ZD | 1 |
Kong, Y | 1 |
Yang, W | 1 |
Zhang, B | 1 |
Zhang, YL | 1 |
Ma, EM | 1 |
Liu, HX | 1 |
Chen, XB | 1 |
Hua, YW | 1 |
Yamamura, A | 1 |
Ono, F | 1 |
Hiraga, M | 1 |
Omura, N | 1 |
Takano, N | 1 |
Sato, H | 1 |
Toyama, S | 1 |
Onochi, S | 1 |
Omori, K | 1 |
Wakabayashi, K | 1 |
Ishibashi, Y | 1 |
Ito, Y | 1 |
Okumura, T | 1 |
Nakamura, J | 1 |
Kai, K | 1 |
Ide, Y | 1 |
Nakamura, H | 2 |
Koga, H | 1 |
Ide, T | 1 |
Miyoshi, A | 1 |
Kitahara, K | 1 |
Noshiro, H | 1 |
Saito, M | 1 |
Kiyozaki, H | 1 |
Takata, O | 1 |
Suzuki, K | 1 |
Rikiyama, T | 1 |
Kunisaki, C | 2 |
Kimura, J | 1 |
Takagawa, R | 1 |
Kanazawa, A | 1 |
Ota, M | 1 |
Kosaka, T | 1 |
Ono, HA | 1 |
Akiyama, H | 1 |
Kono, E | 1 |
Tanaka, N | 2 |
Kudo, K | 1 |
Musha, H | 1 |
Tsuchiya, T | 1 |
Miyachi, T | 1 |
Nagao, M | 1 |
Kajiwara, T | 1 |
Kimura, S | 1 |
Karasawa, H | 1 |
Aoki, T | 2 |
Abe, T | 1 |
Ohnuma, S | 1 |
Nakagawa, K | 1 |
Morikawa, T | 1 |
Yoshida, H | 1 |
Motoi, F | 2 |
Katayose, Y | 1 |
Naito, T | 1 |
Unno, M | 2 |
Hokonohara, K | 1 |
Takata, A | 1 |
Imamura, H | 2 |
Hirota, M | 1 |
Oshima, K | 1 |
Tanida, T | 1 |
Hatano, H | 1 |
Noda, T | 1 |
Komori, T | 1 |
Morita, S | 3 |
Iwazawa, T | 1 |
Akagi, K | 1 |
Adachi, S | 1 |
Dono, K | 1 |
Kikuchi, S | 2 |
Kagawa, S | 1 |
Kuwada, K | 1 |
Kuroda, S | 1 |
Nishizaki, M | 2 |
Tanaka, T | 1 |
Fujiwara, T | 1 |
Nakata, B | 1 |
Yamazoe, S | 1 |
Motomura, H | 1 |
Yamamoto, A | 1 |
Tanaka, S | 2 |
Ohara, T | 1 |
Fujino, Y | 1 |
Goto, H | 2 |
Yamashita, H | 1 |
Oyama, M | 1 |
Katsura, M | 1 |
Sugiyama, H | 1 |
Ueda, Y | 1 |
Hasegawa, H | 1 |
Yasuda, T | 1 |
Kakinoki, K | 1 |
Oshikiri, T | 1 |
Sendo, H | 1 |
Sugimoto, T | 1 |
Tominaga, M | 1 |
Li, Z | 1 |
Mao, W | 1 |
Lin, N | 1 |
Han, S | 1 |
Yamamoto, M | 1 |
Sakaguchi, Y | 1 |
Kinjo, N | 1 |
Yamaguchi, S | 1 |
Egashira, A | 1 |
Minami, K | 1 |
Ikeda, Y | 1 |
Morita, M | 1 |
Toh, Y | 1 |
Okamura, T | 1 |
Yokotani, T | 1 |
Inatsugi, N | 1 |
Yoshikawa, S | 1 |
Masuda, T | 1 |
Uchida, H | 1 |
Kuge, H | 1 |
Yamaoka, K | 1 |
Shimobayashi, T | 1 |
Inagaki, M | 1 |
Yokoo, T | 1 |
Kurisaki, M | 1 |
Miyazawa, Y | 1 |
Sho, M | 1 |
Goto, T | 1 |
Toyama, H | 1 |
Asari, S | 1 |
Terai, S | 1 |
Kinoshita, H | 2 |
Matsumoto, T | 1 |
Kuramitsu, K | 1 |
Tanaka, M | 2 |
Takebe, A | 1 |
Kido, M | 1 |
Matsumoto, I | 1 |
Ajiki, T | 1 |
Fukumoto, T | 1 |
Ku, Y | 1 |
Kim, SG | 1 |
Hwang, SH | 1 |
Kusama, T | 1 |
Yamagami, K | 1 |
Hasegawa, M | 1 |
Sone, N | 1 |
Kokado, Y | 1 |
Koshiba, T | 1 |
Ichikawa, K | 1 |
Koh, M | 1 |
Kishi, K | 1 |
Tsukada, R | 1 |
Tanemura, M | 1 |
Tei, M | 1 |
Masuzawa, T | 1 |
Suzuki, Y | 1 |
Furukawa, K | 1 |
Ikehara, M | 1 |
Akamatsu, H | 1 |
Zhu, Y | 1 |
Sun, Y | 1 |
Hu, S | 1 |
Jiang, Y | 1 |
Yue, J | 1 |
Xue, X | 1 |
Yang, L | 1 |
Xue, L | 1 |
Lee, JJ | 1 |
Kim, SY | 1 |
Chung, HC | 1 |
Lee, KH | 1 |
Song, HS | 1 |
Kang, WK | 1 |
Hong, YS | 1 |
Choi, IS | 1 |
Lee, YY | 1 |
Woo, IS | 1 |
Choi, JH | 1 |
Takada, J | 1 |
Okuda, K | 1 |
Kenno, S | 1 |
Shimada, S | 1 |
Oba, G | 1 |
Shimokuni, T | 1 |
Hamada, H | 1 |
Sugawara, H | 1 |
Ichiki, M | 1 |
Sai, K | 1 |
Kamata, K | 1 |
Ansai, M | 1 |
Nakano, Y | 1 |
Kawamura, M | 1 |
Ichinose, A | 1 |
Miyazaki, S | 1 |
Sato, Y | 3 |
Takayama, T | 1 |
Sagawa, T | 1 |
Takahashi, Y | 1 |
Ohnuma, H | 1 |
Okubo, S | 2 |
Shintani, N | 1 |
Kida, M | 1 |
Ohta, H | 2 |
Miyanishi, K | 1 |
Sato, T | 1 |
Takimoto, R | 1 |
Kobune, M | 1 |
Yamaguchi, K | 1 |
Niitsu, Y | 1 |
Kato, J | 1 |
Furuichi, M | 1 |
Muramatsu, T | 1 |
Shimamura, M | 1 |
Nishii, T | 1 |
Takeshita, S | 1 |
Ishimoto, S | 1 |
Morooka, H | 1 |
Sodeyama, M | 1 |
Sakurai, K | 3 |
Amano, S | 2 |
Ohmori, I | 1 |
Shiono, M | 1 |
Matsuda, S | 1 |
Takahashi, M | 1 |
Watanabe, J | 1 |
Yabuno, T | 1 |
Mochizuki, Y | 1 |
Kito, F | 1 |
Takakura, N | 1 |
Aoki, H | 1 |
Fujiwara, Y | 1 |
Ohno, S | 1 |
Ninomiya, M | 1 |
Iitaka, D | 1 |
Ikoma, H | 1 |
Kawaguchi, T | 1 |
Murayama, Y | 1 |
Kuriu, Y | 1 |
Nakanishi, M | 1 |
Ichikawa, D | 1 |
Ochiai, T | 2 |
Kokuba, Y | 1 |
Sonoyama, T | 1 |
Okada, K | 1 |
Imaizumi, T | 1 |
Yazawa, N | 1 |
Matsuyama, M | 1 |
Dowaki, S | 1 |
Tobita, K | 1 |
Hirabayashi, K | 1 |
Makuuchi, H | 1 |
Watanabe, T | 1 |
Hayashi, T | 1 |
Higuchi, M | 1 |
Suzuki, H | 1 |
Shio, Y | 1 |
Satoh, Y | 1 |
Kitamura, M | 1 |
Gotoh, M | 2 |
Maruyama, R | 1 |
Hirai, F | 1 |
Ondo, K | 1 |
Kometani, T | 1 |
Hamatake, M | 1 |
Seto, T | 1 |
Sugio, K | 1 |
Ichinose, Y | 1 |
Koeda, K | 1 |
Konosu, M | 1 |
Hosoi, N | 1 |
Tamasawa, Y | 1 |
Sase, M | 1 |
Tsukahara, T | 1 |
Ushio, A | 1 |
Taguchi, M | 1 |
Wakabayashi, G | 1 |
Inoue, K | 1 |
Nakane, Y | 1 |
Kogire, M | 1 |
Fujitani, K | 1 |
Tamura, S | 1 |
Okano, S | 1 |
Kwon, AH | 1 |
Shimokawa, T | 1 |
Takiuchi, H | 1 |
Tsujinaka, T | 2 |
Furukawa, H | 1 |
Kitasato, Y | 1 |
Yasunaga, M | 1 |
Nakayama, M | 1 |
Akasu, G | 1 |
Yoshitomi, M | 1 |
Mikagi, K | 1 |
Kawahara, R | 1 |
Ishikawa, H | 1 |
Hisaka, T | 1 |
Horiuchi, H | 1 |
Okabe, Y | 1 |
Hamakawa, T | 1 |
Takiguchi, S | 1 |
Miyata, H | 1 |
Dok, Y | 1 |
Sakurai, N | 1 |
Yamamoto, K | 2 |
Kakizaki, Y | 1 |
Tamura, G | 1 |
Iizawa, H | 1 |
Sakabe, R | 1 |
Nakashima, A | 1 |
Ohge, H | 1 |
Hiyama, E | 1 |
Katoh, R | 1 |
Takeyoshi, I | 1 |
Sunose, Y | 1 |
Yoshinari, D | 1 |
Totsuka, O | 1 |
Toya, H | 1 |
Ogawa, H | 1 |
Hirai, K | 1 |
Mori, Y | 1 |
Ohtani, H | 1 |
Tamamori, Y | 1 |
Inoue, T | 1 |
Azuma, T | 1 |
Yamamoto, Y | 2 |
Nakai, N | 1 |
Wakabayashi, Y | 1 |
Okuzawa, Y | 1 |
Asai, J | 1 |
Takenaka, H | 1 |
Katoh, N | 1 |
Takii, M | 1 |
Kuroda, K | 1 |
Asano, Y | 1 |
Noda, E | 1 |
Yamada, N | 1 |
Umemoto, S | 1 |
Hosaka, S | 1 |
Kikutake, T | 1 |
Maeno, H | 1 |
Inada, K | 1 |
Nagao, S | 1 |
Kawamoto, S | 1 |
Yoshida, T | 2 |
Kaneko, S | 1 |
Itsui, Y | 1 |
Hashiguchi, M | 1 |
Watanabe, M | 2 |
Yoshida, R | 1 |
Akashi, T | 1 |
Yauchi, T | 1 |
Yamamoto, S | 1 |
Nakamura, K | 1 |
Katai, H | 1 |
Nashimoto, A | 1 |
Fukushima, N | 1 |
Abe, S | 1 |
Kojima, M | 1 |
Kurihara, H | 1 |
Tamura, H | 1 |
Kitago, M | 1 |
Sasanuma, H | 1 |
Wada, M | 1 |
Ogihara, T | 1 |
Ohchi, T | 1 |
Kudo, S | 1 |
Ogata, K | 1 |
Nakamura, T | 1 |
Koga, Y | 1 |
Ishiodori, H | 1 |
Ishihara, A | 1 |
Tanaka, A | 1 |
Funai, S | 1 |
Ohtsuka, H | 1 |
Yoshifuji, T | 1 |
Hirai, T | 1 |
Shindo, K | 1 |
Shiozaki, H | 1 |
Kamei, A | 1 |
Egawa, T | 1 |
Nagashima, A | 1 |
Kitano, M | 1 |
Doi, M | 1 |
Hayashi, S | 1 |
Yoshii, H | 1 |
Obara, S | 1 |
Mishima, K | 1 |
Yoshimura, Y | 1 |
Deguchi, Y | 1 |
Shioya, M | 1 |
Sakai, M | 1 |
Takenaka, K | 1 |
Doi, H | 1 |
Komai, Y | 1 |
Higuchi, A | 1 |
Yasuda, A | 1 |
Mizuno, I | 1 |
Mohri, N | 1 |
Matsumoto, K | 1 |
Fukaya, S | 1 |
Shinagawa, N | 1 |
Manabe, T | 1 |
Yoneyama, K | 1 |
Sugano, N | 1 |
Jin, Y | 1 |
Kasahara, A | 1 |
Takanashi, Y | 2 |
Yamada, K | 1 |
Sugiyama, Y | 1 |
Seino, K | 1 |
Kobori, H | 1 |
Ebina, T | 1 |
Shibata, S | 1 |
Kawasaki, H | 1 |
Sasaki, M | 1 |
Takagi, T | 1 |
Ueda, N | 1 |
Kanemoto, H | 1 |
Shoji, T | 1 |
Fukasawa, T | 1 |
Nakajima, T | 1 |
Morita, Y | 1 |
Kikuchi, Y | 1 |
Shirakawa, T | 1 |
Yokoi, K | 1 |
Ishikawa, N | 1 |
Seya, T | 1 |
Horiba, K | 1 |
Kanazawa, Y | 1 |
Okawa, K | 1 |
Yoshioka, M | 1 |
Oaki, Y | 1 |
Tokunaga, A | 1 |
Tajiri, T | 1 |
Kobayashi, K | 1 |
Ueki, K | 1 |
Wakakuwa, R | 1 |
Ishizuka, D | 1 |
Tada, T | 1 |
Hiramatsu, K | 1 |
Kato, K | 1 |
Hirata, A | 1 |
Matsuba, H | 1 |
Hara, T | 1 |
Ito, T | 1 |
Miyata, T | 1 |
Akagawa, T | 1 |
Kutsuna, Y | 1 |
Machiki, Y | 1 |
Fujioka, S | 1 |
Saze, Z | 1 |
Terashima, M | 1 |
Otani, S | 1 |
Soeta, N | 1 |
Kashimura, S | 1 |
Osuka, F | 1 |
Odashima, Y | 1 |
Saito, T | 1 |
Hoshino, Y | 1 |
Kogure, M | 1 |
Watanabe, K | 1 |
Doi, T | 1 |
Okuda, T | 2 |
Fujimi, A | 1 |
Kanisawa, Y | 1 |
Izumi, K | 1 |
Kitahara, T | 1 |
Tokuhara, T | 1 |
Sakata, C | 1 |
Nishikawa, M | 1 |
Morita, R | 1 |
Murakami, H | 1 |
Yamakawa, M | 1 |
Han, I | 1 |
Hatori, S | 1 |
Suzuki, M | 1 |
Iwasaki, H | 1 |
Tazawa, K | 1 |
Matsui, K | 1 |
Shinbo, M | 1 |
Yamagishi, F | 1 |
Yamada, A | 1 |
Tsukada, K | 1 |
Enomoto, K | 1 |
Kitajima, A | 1 |
Tani, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase II Study of Paclitaxel Liposome Plus S-1 as Neoadjuvant Chemotherapy for Advanced Gastric Cancer[NCT02163291] | Phase 2 | 30 participants (Anticipated) | Interventional | 2013-12-31 | Not yet recruiting | ||
Apatinib Plus XELOX Regime as Neoadjuvant Therapy in Locally Advanced Gastric Cancer Patients With Lymph Node Metastasis[NCT03229096] | Phase 2 | 35 participants (Anticipated) | Interventional | 2017-02-01 | Recruiting | ||
The Exploratory Study of Conversion Surgery for Apatinib in Combination With Oxaliplatin/S-1(SOX) for Patients With Unresectable Gastric Cancer[NCT03007446] | Phase 2 | 20 participants (Anticipated) | Interventional | 2016-11-30 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for oxonic acid and Invasiveness, Neoplasm
Article | Year |
---|---|
[A case of locally advanced gastric cancer in which pathological complete response( PCR) was obtained after combination chemotherapy with S-1/cisplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastric Bypass; | 2013 |
[An Elderly Patient with Local Recurrence of Gastric Cancer Responding Completely to S-1 Monotherapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Gastrectomy; Humans; Lymphati | 2016 |
[Locally recurrent case of gastric cancer with serosal invasion after four months of endoscopic submucosal dissection].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Endos | 2012 |
6 trials available for oxonic acid and Invasiveness, Neoplasm
Article | Year |
---|---|
Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; H | 2014 |
Concurrent radiotherapy with S-1 plus cisplatin versus concurrent radiotherapy with cisplatin alone for the treatment of locally advanced cervical carcinoma: a pilot randomised controlled trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Drug Combinations; Fem | 2016 |
A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Comb | 2009 |
Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogen | 2010 |
Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D | 2012 |
Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D | 2012 |
Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D | 2012 |
Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D | 2012 |
Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Adminis | 2013 |
69 other studies available for oxonic acid and Invasiveness, Neoplasm
Article | Year |
---|---|
Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy.
Topics: Aged; Cell Line, Tumor; Cell Proliferation; Chemotherapy, Adjuvant; Digestive System Surgical Proced | 2019 |
Plasma microRNA profiles: identification of miR-1229-3p as a novel chemoresistant and prognostic biomarker in gastric cancer.
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Survival; Disease-Free Survival; D | 2020 |
Role of Conversion Surgery for Unresectable Pancreatic Cancer After Long-Term Chemotherapy.
Topics: Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycyti | 2020 |
[A Case of Duodenal Invasive Advanced Gastric Cancer in Which the Primary Tumor Achieved pCR, but Viable Cancer Cells Remained in Lymph Node No.13 after Neoadjuvant Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Duodenum; Female; Gastrecto | 2017 |
[Laparoscopic Total Gastrectomy with Pancreatosplenectomy after Neoadjuvant Chemotherapy for Advanced Gastric Cancer with Adjacent Organs Invasion].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Hum | 2017 |
Gallbladder cancer with tumor thrombus in the portal vein: A case report.
Topics: Administration, Intravenous; Antineoplastic Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; D | 2018 |
[A Case of Type 4 Gastric Cancer with Esophageal Invasion That Responded to Neoadjuvant Chemotherapy Containing S-1 and Oxaliplatin followed by Surgery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Esophagus; Gastrectomy | 2018 |
Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; | 2013 |
[A case of advanced gastric cancer with esophageal invasion treated by neoadjuvant S-1/CDDP chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Esophagus; Gastr | 2013 |
[A case of locally advanced pancreatic cancer with hepatic artery invasion treated with neoadjuvant chemoradiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Deoxycytidine; Drug Combinations; | 2013 |
[A case of combined resection of multiple adjacent organs in a patient with locally advanced residual gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2013 |
Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetu | 2014 |
[A case of a patient with gastric cancer and peritoneal dissemination who survived for more than 10 years after successful treatment with S-1].
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Female; Gastrectomy; | 2014 |
[A case of gastric cancer with N2 lymph node metastasis and pancreatic invasion effectively treated with docetax-el/S-1 as a neoadjuvant chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Lymphati | 2014 |
Curative resection of gallbladder cancer with liver invasion and hepatic metastasis after chemotherapy with gemcitabine plus S-1: report of a case.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, | 2014 |
Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Mod | 2014 |
Impact of S-1 plus Cisplatin Neoadjuvant Chemotherapy on Scirrhous Gastric Cancer.
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy | 2015 |
[Two cases of advanced gastric cancer achieved pathological complete response by preoperative chemotherapy with S-1 plus weekly low-dose CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2014 |
[A case report of advanced gastric cancer with bulky lymph node metastases successfully treated with induction chemotherapy followed by curative resection].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gastrectomy; Humans; Induction Che | 2014 |
[Pathological complete response in a case of advanced gastric cancer after neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Humans; M | 2014 |
Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2015 |
[A case of stage IV b pancreatic head cancer that was resected because of a good response to chemotherapy].
Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Drug Combinations; Fatal Outcome; Female; Gemcitabin | 2015 |
S-1 Adjuvant Chemotherapy Earlier After Surgery Clinically Correlates with Prognostic Factors for Advanced Gastric Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Com | 2016 |
[A Case of Long-Term Survival after Pancreatoduodenectomy for Gastric Cancer with Pancreatic Invasion].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gastrectomy; Humans; Neoplasm Inva | 2015 |
[A Case of Invasive Intraductal Papillary Mucinous Carcinoma, Penetrating the Stomach, Colon, and Jejunum].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Chemotherapy, Ad | 2015 |
The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cape | 2016 |
[Curative Resection for Chemorefractory Advanced Gastric Cancer with Pancreatic Invasion by Pancreatoduodenectomy - A Case Report].
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothec | 2016 |
Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 2017 |
[S-1+gemcitabine (GEM) therapy was effective in a case of unresectable pancreatic head carcinoma].
Topics: Aged; Angiography; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Deoxycytidine; | 2008 |
[Noticeable clinical response to S-1/CDDP combination therapy for Virchow node recurrence after surgery for advanced gastric carcinoma with marked involvement of the esophagus - report of a case].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Drug Combination | 2009 |
[Treatment with S-1 and radiation therapy for advanced lung cancer invading chest wall].
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Humans; Lung Neoplasm | 2010 |
[A case report of bi-weekly docetaxel and S-1 combination chemotherapy for gastric cancer with multiple liver metastases and esophageal invasion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Esophageal Neoplasms; | 2010 |
[A 6-year survival case of locally advanced unresectable pancreatic tail cancer treated with chemo-radiation therapy].
Topics: Combined Modality Therapy; Deoxycytidine; Drug Combinations; Fatal Outcome; Gemcitabine; Humans; Lym | 2010 |
[A case report--locally advanced pancreatic adenocarcinoma was resected after chemotherapy].
Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin; Combined M | 2010 |
Curative surgical treatment after preoperative chemotherapy for primarily inoperable locally advanced pancreatic carcinoma: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Female; Gemcitabin | 2009 |
Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuv | 2011 |
A case of gastric cancer accompanied with massive splenic invasion by metastatic lymph nodes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Endoscopy, Digestive S | 2011 |
[A case of long-term survival after resection of aortic arch for locally advanced non-small cell lung cancer with induction chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta, Thoracic; Carcinoma, Non-Small-Cell Lung; Cis | 2011 |
Concurrent chemoradiotherapy using cisplatin plus S-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: a single-center feasibility study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Sm | 2011 |
[A case of advanced adenocarcinoma of esophagogastric junction with severe esophageal invasion effectively treated by chemoradiotherapy using paclitaxel and cisplatin, and S-1 after chemoradiotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality T | 2011 |
[A case of peritoneal recurrence of invasive carcinoma derived from IPMN after distal pancreatectomy].
Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Chemoradiotherapy; Deoxycytidine; Drug Combinat | 2011 |
[Combination chemotherapy using docetaxel, cisplatin, and S-1 for far advanced gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations | 2011 |
[A case of curatively resected locally advanced cancer of the pancreatic body treated by distal pancreatectomy with en bloc celiac axis resection after neoadjuvant chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Fatal Outcom | 2012 |
Prognostic significance of telomerase activity and human telomerase reverse transcriptase expression in ampullary carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Ampulla of Vater; Antineoplastic Agents; Biomarkers, Tumor; Carcinom | 2012 |
[A case of pancreatic cancer with celiac trunk and common hepatic artery invasion successfully resected after gemcitabine+S-1therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Celiac Artery; Deoxycytidine; Drug Combinations; Fem | 2012 |
[Two cases of stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans; Liver Ne | 2012 |
A case of advanced cutaneous squamous cell carcinoma of the lower eyelid that was successfully treated with tegafur-gimeracil-oteracil potassium monotherapy.
Topics: Administration, Oral; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; | 2012 |
[A case of advanced gastric cancer with esophageal severe dysplasia resected after neoadjuvant S-1+cisplatin therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Esophageal Neopl | 2012 |
[A case of gastric neuroendocrine carcinoma with liver metastasis and portal vein invasion successfully treated by S-1 and cisplatin chemotherapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Neuroendocrine; Cisplatin; Drug C | 2013 |
[A case of residual gastric cancer accompanied by esophageal invasion in which residual lesions were eradicated by half-dose administration of TS-1].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Drug Combinations; Esophageal Neoplasms; Gastrectom | 2002 |
[A case of advanced gastric cancer with invasion of pancreas effectively treated by combined chemotherapy of TS-1 and paclitaxel (TXL)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule | 2002 |
[A patient with advanced gastric cancer that response remarkably to combination chemotherapy of TS-1 and biweekly paclitaxel (TXL)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Drug Administration S | 2003 |
[A case of advanced gastric cancer that had invaded the duodenum treated with combined chemotherapy using TS-1 and low-dose CDDP, which prevented the need for a pancreaticoduodenectomy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relat | 2003 |
[An advanced case of squamous cell carcinoma in the left buccal mucosa, upper gingiva, and maxillary sinus (T4N0M0) showing a complete response to chemotherapy with TS-1].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Administrat | 2004 |
[A case of advanced gastric cancer with pulmonary carcinomatous lymphangiosis responding remarkably to combination chemotherapy of docetaxel (TXT) and TS-1].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Sched | 2005 |
[Successfully resected advanced gastric carcinoma after combined chemotherapy of TS-1 plus CDDP--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality T | 2005 |
[A case of advanced gastric cancer effectively treated by combined chemotherapy of TS-1 and paclitaxel].
Topics: Aged; Anastomosis, Roux-en-Y; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant | 2005 |
[A Case of advanced gastric cancer successfully treated with TS-1/low-dose CDDP as neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; | 2005 |
[Effective treatment of unresectable advanced gastric cancer by TS-1-based chemotherapy with a sequential combination of cisplatin (CDDP) and paclitaxel (PTX)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug | 2005 |
[A case of gastric cancer with liver invasion responding to TS-1/low-dose CDDP chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug | 2005 |
[A case of advanced gastric cancer successfully treated by TS-1 and CDDP after jejunostomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Admini | 2006 |
[A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Comb | 2006 |
[A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Squamous Cell; C | 2007 |
[A case of advanced gastric cancer responding remarkably to neo-adjuvant combination chemotherapy using CPT-11 plus S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch | 2007 |
[A case of unresectable advanced pancreatic cancer with peritoneal dissemination responding to continuous dose S-1 monotherapy after chemo-radiation therapy].
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Deoxycytidine; Drug Combinations; Female | 2007 |
[Resection of cancer of the cardia enabled by combined treatment with S-1 and paclitaxel after esophageal stenting for impaired patency complicating stage IV gastric cancer - a case report].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic C | 2007 |
[Neoadjuvant chemotherapy with combination of S-1 and CPT-11 in advanced rectal cancer - a case report].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemothe | 2007 |
[A case of unresectable gastric cancer presenting pylorus stenosis treated orally with S-1 therapy after gastrojejunostomy].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Constriction, Pathologic; Drug Administ | 2007 |
[A case of advanced breast cancer successfully treated with multi-disciplinary therapy and S-1 administration].
Topics: Biopsy, Needle; Breast Neoplasms; Drug Combinations; Female; Humans; Magnetic Resonance Imaging; Mid | 2007 |